1 |
Rainer, M., Sajdik, C. and Bonn, G. K. : Mass spectrometric profiling of low-molecular-weight proteins. Methods. Mol. Biol. 1023, 83 (2013).
DOI
ScienceOn
|
2 |
Wu, S. Y., Kuo, J. W., Chang, T. K., Liu, R. S., Lee, R. C., Wang, S. J., Lin, W. J. and Wang, H. E. : Preclinical characterization of 18F-MAA, a novel PET surrogate of 99mTc-MAA. Nucl. Med. Biol. 39, 1026 (2012).
DOI
ScienceOn
|
3 |
Günel, S. E. and Akgun, A. : Comparison of exercise-restreinjection Tl-201 imaging and rest sublingual isosorbide dinitrate Tc-99m MIBI imaging for the assessment of myocardial viability. Ann. Nucl. Med. 23, 451 (2009).
DOI
|
4 |
Narayanan, M. V., King, M. A. and Byrne, C. L. : An iterative transmission algorithm incorporating cross-talk correction for SPECT. Med. Phys. 29, 694 (2002).
DOI
ScienceOn
|
5 |
Abbasi, I. A. : Preliminary studies on (177)Lu-labeled sodium pyrophosphate (177Lu-PYP) as a potential bone-seeking radiopharmaceutical for bone pain palliation. Nucl. Med. Biol. 39, 763 (2012).
DOI
ScienceOn
|
6 |
Brans, B., Mottaghy, F. M. and Kessels, A. : 90Y/177Lu- DOTATATE therapy: survival of the fittest? Eur. J. Nucl. Med. Mol. Imaging. 38, 1785 (2011).
DOI
|
7 |
Seidl, C. and Essler, M. : Radioimmunotherapy for peritoneal cancers. Immunotherapy 5, 395 (2013).
DOI
ScienceOn
|
8 |
Ozkan, E., Aras, G. and Kucuk, N. O. : Correlation of 18F-FDG PET/CT findings with histopathological results in differentiated thyroid cancer patients who have increased thyroglobulin or antithyroglobulin antibody levels and negative 131I wholebody scan results. Clin. Nucl. Med. 38, 326 (2013).
DOI
|
9 |
Chakravarty, R., Dash, A. and Pillai, M. R. : Availability of yttrium-90 from strontium-90: a nuclear medicine perspective. Cancer. Biother. Radiopharm. 27, 621 (2012).
DOI
ScienceOn
|
10 |
Snyder, E. H., O'Connor, G. A. and McAvoy, D. C. : Fate of 14C-triclocarban in biosolids-amended soils. Sci. Total. Environ. 408, 2726 (2010).
DOI
ScienceOn
|
11 |
Wiwanitkit, V. : 177Lu-nimotuzumab. Nucl. Med. Biol. 39, 891 (2012).
DOI
ScienceOn
|